<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200604047650N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-08-09</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of rehabilitation on stroke</public_title>
      <acronym></acronym>
      <scientific_title>The effect of cognitive rehabilitation and non-invasive brain stimulation on cognitive abilities and daily living activities of patients after ischemic stroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-07-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/48962</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Using stratified block random sampling(regarding the hemogeneity of groups in terms of gender( female/ male) and the intensity of ischemia(mild/moderate)) and RehaCom software with  transcranial direct current stimulation(tdcs), the will divide samples to two intervention and sham groups. In fact, considering the gender and the intensity of ischemia( mild/ moderate), 4 strata will be formed in each of them four block random sampling will be used to assign patients to two intervention group and sham group.To this aim, first the researcher will write  a list of  blocks and assign number them (AABB-ABAB-BBAA-BABA-BAAB) the using random number table, the researcher will randomly select numbers between 1 to 6, and in this way, she will be provided with a list of treatment assignment, based on a sequence of letters A and B, Blinding description: This study will be double blind that is participants and data analysts will be blinded. Participants will all be willing to participate in the study but will not know whether they will be included in the intervention group or the sham
 one. group members will be fed into the  statistical software  with  a code. Therefore data analyzer will not know to which group the extracted data  will belong. Therefore,  it will be  a double blind study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cognitive disorders due to cerebral infarction.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, the researcher uses two methods of non-invasive electrical stimulation intervention and Rehacom rehabilitation software. After the patient is seated in a comfortable chair, where the monitor is in front of him and he has access to the software's keyboard, he is assured of support and support during rehabilitation. Anode and cathode electrodes are placed on the patient's head based on the location of the 10-20 system. The patient is then evaluated by RehaCom software. Based on the results of the evaluation and based on the software proposal, the desired modules are performed with emphasis on the executive functions for the patient. It should be noted that 30 seconds before the start of rehabilitation, the tdcs device is turned on and the stimulation is applied to the patient's scalp in the dorsolateral prefrontal cortex(F3) area through the anode electrode and continues for 20 minutes. It should be noted that while performing brain stimulation, the person is performing cognitive exercises of RehaCom software. Generally, intervention phase  will last 12 sessions, 3 sessions a week. Intervention 2: Control group: In the current study, RehaCom's rehabilitation software and non invaisive brain stimulation (TDCS) device will also be used for the sham group. In fact, in the sham group, 30 seconds before starting the rehabilitation with  RehaCom software, after placing electrodes on the skull, the TDCS will be switched on and the stimulatin will be applied at a voltage of 2 MA just like that in the intervention group. The only point of difference is that after 30 seconds and simultaneous with the onset of the  cognitive rehabilitation the device automatically will shut off. However the rehabilitation will continue using RehaCom. It should be noted that the intervention  will last 12 session, 3 sessions a week. Moreover, the group in which the TDCS divice will automatically shut off after 30 seconds is called the sham group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is As a legal entity, Lorestan University of Medical Sciences owns the data, and as an independent researcher, I do not have the right to publish any data. By obtaining legal permits from Lorestan University of Medical Sciences, information can be provided to others if needed.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Negin Kordestani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Kiani Alley, Farzanegan 1 Alley, Naser khosro St, Khorram abad</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6814955373</zip>
        <telephone>+98 66 3321 3531</telephone>
        <email>kordestaninegin@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>parastou kordestani maghaddam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and midwifery school, Lorestan University of Medical Sciences, 4 km of Khorramabad-Boroujerd road, Kamalvand, Khorramabad</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>381251698</zip>
        <telephone>+98 66 3312 0140</telephone>
        <email>kparastou@yahoo.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 40 to 65 years
Have a minimum of literacy
Patients diagnosed with ischemic stroke in the last three months
Ischemia of the right hemisphere of the brain
Get a score of less than 24 on a Mini-mental state examination
Score between 15-1 in Modified national of health stroke scale</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Disruption of delicate balance movements, especially the right hand
Having implantable metal objects (pacemakers, implants, brain clips, etc.)
Taking antidepressants, anticonvulsants, hypnotics and muscle relaxants
History of previous cerebral ischemic stroke
Motor impairment and subsequent inability to visit the clinic</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other vascular syndromes of brain in cerebrovascular diseases</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, the researcher uses two methods of non-invasive electrical stimulation intervention and Rehacom rehabilitation software. After the patient is seated in a comfortable chair, where the monitor is in front of him and he has access to the software's keyboard, he is assured of support and support during rehabilitation. Anode and cathode electrodes are placed on the patient's head based on the location of the 10-20 system. The patient is then evaluated by RehaCom software. Based on the results of the evaluation and based on the software proposal, the desired modules are performed with emphasis on the executive functions for the patient. It should be noted that 30 seconds before the start of rehabilitation, the tdcs device is turned on and the stimulation is applied to the patient's scalp in the dorsolateral prefrontal cortex(F3) area through the anode electrode and continues for 20 minutes. It should be noted that while performing brain stimulation, the person is performing cognitive exercises of RehaCom software. Generally, intervention phase  will last 12 sessions, 3 sessions a week</i_keyword>
      <i_keyword>Control group: In the current study, RehaCom's rehabilitation software and non invaisive brain stimulation (TDCS) device will also be used for the sham group. In fact, in the sham group, 30 seconds before starting the rehabilitation with  RehaCom software, after placing electrodes on the skull, the TDCS will be switched on and the stimulatin will be applied at a voltage of 2 MA just like that in the intervention group. The only point of difference is that after 30 seconds and simultaneous with the onset of the  cognitive rehabilitation the device automatically will shut off. However the rehabilitation will continue using RehaCom. It should be noted that the intervention  will last 12 session, 3 sessions a week. Moreover, the group in which the TDCS divice will automatically shut off after 30 seconds is called the sham group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cognitive functions. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Cognitive evaluation( attention and concentration, visual memory, reactive behavior, and logical thinking) by Rehacom software screening test scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Basic activity of daily living, Advance activity of daily living. Timepoint: before intervention and 4 weeks after intervention. Method of measurement: Barthel index, Lawton Index.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khoram-Abad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-06-06</approval_date>
        <contact_name>Ethics committee of Lorestan university of medical sciences</contact_name>
        <contact_address>Nursing and midwifery faculty, Lorestan medical sciences university, 4 kilometers of Khorramabad- Boroujerd road, Khorramabad khorramabad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
